NCMB names new CEO
The North Carolina Medical Board has named Thomas W. Mansfield, JD, as its new Chief Executive Officer. Prior to accepting the position of CEO, Mr. Mansfield served as the organization’s Chief…
Read More…Managing xylazine exposure in opioid overdose patients
In North Carolina and across the nation, the veterinary sedative xylazine is increasingly detected in the illicit opioid drug supply and in opioid overdoses. Toxicology data from major US regions…
Read More…New SUD training requirement for DEA registrants
NCMB has received inquiries about a new federal training requirement that affects all prescribers with a valid DEA registration, regardless of whether they prescribe opioids or treat patients with…
Read More…